๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ignorability and bias in clinical trials

โœ Scribed by Daniel F. Heitjan


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
123 KB
Volume
18
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

โœฆ Synopsis


Patient non-compliance and drop-out can bias analyses of clinical trial data. I describe a parametric model for treatment cross-over and drop-out and demonstrate how the concept of ignorability, originally de"ned for incomplete-data problems, can elucidate sources of bias in clinical trials. I discuss some implications of the theory and present simulation examples that illustrate the potential e!ects of non-ignorable cross-over and drop-out on bias and power.


๐Ÿ“œ SIMILAR VOLUMES


Selection bias and treatment heterogenei
โœ Nicholas T. Longford ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 1 views

A common perception about many commercially available medical treatments is that they are e!ective for every patient having the relevant indication and that developers have provided the regulatory authorities with evidence of such a property. We show that the standard of evidence is much lower and t

Attitudes in clinical trials
โœ Peter Armitage ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

Two important papers by Schwartz and Lellouch have drawn distinctions between explanatory and pragmatic attitudes to clinical trials, and between individual and collective ethics. The pragmatic approach accords with the widespread use of 'intention-to-treat' analyses, but recent research has started

Clinical trials in neurology
โœ Karl D. Kieburtz ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 42 KB ๐Ÿ‘ 2 views